Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Comparison Table: NAD⁺, NMN, NR

Compound Structure/Source Bioavailability Conversion to NAD⁺ Research Use Typical Dosing Safety Profile Supplement Status NAD⁺ Core coenzyme, not orally stable Poor orally N/A (already NAD⁺) IV/injection in trials 250–1,000 mg IV Good in short trials IV clinic

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Compound
  • Structure/Source
  • Bioavailability
  • Conversion to NAD⁺
  • Research Use
  • Typical Dosing
  • Safety Profile
  • Supplement Status
  • NAD⁺
  • Core coenzyme, not orally stable
  • Poor orally
  • N/A (already NAD⁺)
  • IV/injection in trials
  • 250–1,000 mg IV
  • Good in short trials
  • IV clinics, research
  • NMN
  • B3 derivative, found in broccoli, avocados
  • Good orally
  • Directly to NAD⁺ (via NR)
  • Anti-aging, metabolic
  • 100–1,250 mg/day
  • Safe up to 1,250 mg/day
  • Widely available
  • NR
  • B3 derivative, in milk, yeast, beer
  • Direct to NAD⁺
  • 100–2,000 mg/day
  • Safe up to 2,000 mg/day